🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Two-way Study to Evaluate the Potential Pharmacokinetic Interactions Betw...
Status
Unknown
Location
Lexicon Investigational Site
Start Date
2015-07
Trial ID
NCT02494609
Treatments Being Tested
The purpose of this study is to evaluate the effectiveness of anti-HER2 the...
Status
Unknown
Location
Sun Yat-sen University Cancer Center
Start Date
2020-07-01
Trial ID
NCT04337658
Treatments Being Tested
The purpose of this study is to determine the safety, tolerability and phar...
Status
Completed
Location
ATTN-Research Pharmacist
Start Date
2012-04-30
Trial ID
NCT01597193
Treatments Being Tested
This is a randomized trial for patients with metastatic hormone receptor (H...
Status
Completed
Location
University of Alabama at Birmingham (UAB)
Start Date
2016-03
Trial ID
NCT02632045
Treatments Being Tested
The purpose of this study is to compare the natural cycle (without any medi...
Status
Unknown
Location
IVI Valencia
Start Date
2011-05
Trial ID
NCT01353846
Treatments Being Tested
This study adopts multicenter/randomized trial design. It plans to enroll p...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-04-30
Trial ID
NCT06941142
Treatments Being Tested
The main objective of this trial is to demonstrate the contraceptive effica...
Status
Completed
Location
Fellows Research Alliance, Inc.
Start Date
2019-12-03
Trial ID
NCT03945513
Treatments Being Tested
The goals of this clinical research study are to learn the tolerable and ef...
Status
Terminated
Location
UT MD Anderson Cancer Center
Start Date
2009-11
Trial ID
NCT00903006
Treatments Being Tested
The aim of this study is to determine whether or not continuous combined or...
Status
Withdrawn
Location
University of Oklahoma Health Sciences Center
Start Date
2009-10
Trial ID
NCT00999479
Treatments Being Tested
SAFIR PI3K is an open-label multicenter phase II randomized trial, comparin...
Status
Terminated
Location
Institut de Cancérologie de l'Ouest/Paul Papin
Start Date
2018-03-15
Trial ID
NCT03386162
Treatments Being Tested